Amdocs (FRA:AOS) Other Long Term Assets: €606 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AOS Amdocs Ltd FRA:AOS
72 GF Score
Price €49.59
GF Value €74.49
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Amdocs Other Long Term Assets?

Amdocs FRA:AOS +0.24% 72 Other Long Term Assets is €606 Mil as of Jun. 2026. GuruFocus rates FRA:AOS with a GF Score™ of 72/100 and a GF Value™ of €74.49 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Amdocs's other long-term assets for the quarter that ended in Jun. 2026 was €606 Mil.

Amdocs's quarterly other long-term assets increased from Dec. 2025 (€537 Mil) to Mar. 2026 (€592 Mil) and increased from Mar. 2026 (€592 Mil) to Jun. 2026 (€606 Mil).

Amdocs's annual other long-term assets increased from Sep. 2023 (€592 Mil) to Sep. 2024 (€635 Mil) but then declined from Sep. 2024 (€635 Mil) to Sep. 2025 (€562 Mil).

Amdocs Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Amdocs's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amdocs Other Long Term Assets Chart

Amdocs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 536.07 580.69 591.79 634.73 562.39

Amdocs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 585.66 562.39 536.99 592.12 605.83
FRA:AOS
72GF Score
Amdocs Ltd FRA:AOS
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amdocs Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of €606 Mil mean?
Amdocs (FRA:AOS) has a Other Long Term Assets of €606 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Amdocs and its competitors.
Is Amdocs' Other Long Term Assets too high?
Amdocs' current Other Long Term Assets is €606 Mil. Overall, Amdocs has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amdocs' Other Long Term Assets compare to PATH and ACIW?
Amdocs' Other Long Term Assets of €606 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Software company?
A good Other Long Term Assets depends on the Software industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Amdocs and its competitors. Amdocs's current Other Long Term Assets is €606 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amdocs stock overvalued right now?
Based on GuruFocus' analysis, Amdocs (FRA:AOS) is currently considered Significantly Undervalued. The stock's GF Value™ is €74.49, compared to a current price of €49.59 — trading 33.4% below its estimated fair value. The current Other Long Term Assets is €606 Mil. Amdocs' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Amdocs (FRA:AOS), the current Other Long Term Assets is €606 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amdocs (FRA:AOS) Overvalued in 2026?

Based on GuruFocus' analysis, Amdocs stock appears to be undervalued. The current stock price of €49.59 is trading 33.4% below its estimated GF Value™ of €74.49. GuruFocus considers Amdocs to be Significantly Undervalued.

Key valuation signals for FRA:AOS:

  • Other Long Term Assets: €606 Mil
  • GF Value™: €74.49 vs. price of €49.59 (33.4% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the FRA:AOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amdocs Business Description

Address 625 Maryville Centre Drive, Suite 200, Saint Louis, MO, USA, 63141
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
72GF Score

Get the complete analysis for FRA:AOS

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.59
Price
€74.49
GF Value